December 5, 2016 / 9:22 AM / in a year

BRIEF-Novelion's Aegerion Pharmaceuticals enters into licensing agreement with Amryt Pharma

Dec 5 (Reuters) - Novelion Therapeutics Inc

* Novelion therapeutics subsidiary, Aegerion Pharmaceuticals, enters into licensing agreement with Amryt Pharma for Lojuxta (Lomitapide)

* Novelion - Under agreement, Amryt will receive exclusive license to promote,distribute Lojuxta in European economic area, Switzerland, Turkey

* Novelion- Amryt will receive exclusive license to promote, distribute Lojuxta in certain middle eastern, north African countries, including Israel

* Amryt will pay Aegerion sales-related milestone payments and royalties on product sales in licensed territories

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below